tirzepatide in pregnancy Tirzepatide, Birth Control, and tirzepatide pregnancy discontinue before conception

Overall, people using any anti-obesity medication had a 27% lower risk of osteoarthritis compared to people not using medication

Tirzepatide targets two key receptors: GLP-1 and glucose-dependent insulinotropic polypeptide (GIP)

Rare Semaglutide Side Effects Pulmonary side effects are rare with semaglutide use

Besides the acute phase gastrointestinal effects which may lead to up to 10% of people discontinuing the drugs, there are other potential GI side effects of obstruction, excessive loss of muscle mass, and potentially association with some eye disease adverse events

Ozempic (semaglutide) and Mounjaro (tirzepatide) are licensed for the treatment of type 2 diabetes